Literature DB >> 12682333

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

J M van der Walt1, E R Martin, W K Scott, F Zhang, M A Nance, R L Watts, J P Hubble, J L Haines, W C Koller, K Lyons, R Pahwa, M B Stern, A Colcher, B C Hiner, J Jankovic, W G Ondo, F H Allen, C G Goetz, G W Small, F Mastaglia, A D Roses, J M Stajich, M W Booze, K Fujiwara, R A Gibson, L T Middleton, B L Scott, M A Pericak-Vance, J M Vance.   

Abstract

Recently, the authors demonstrated linkage in idiopathic PD to a region on chromosome 8p that contains the N-acetyltransferase genes, NAT1 and NAT2. The authors examined NAT1 and NAT2 for association with PD using family-based association methods and single nucleotide polymorphisms (SNPs). The authors did not find evidence for association with increased risk for PD between any individual NAT1 or NAT2 SNP or acetylation haplotype (N = 397 families, 1,580 individuals).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682333     DOI: 10.1212/01.wnl.0000055929.84668.9a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.

Authors:  N Palacios; M Weisskopf; K Simon; X Gao; M Schwarzschild; A Ascherio
Journal:  Parkinsonism Relat Disord       Date:  2010-03-20       Impact factor: 4.891

2.  mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice.

Authors:  Mariola Kulawiec; Kjerstin M Owens; Keshav K Singh
Journal:  J Hum Genet       Date:  2009-09-18       Impact factor: 3.172

3.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

4.  N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.

Authors:  Juergen Borlak; Stella Marie Reamon-Buettner
Journal:  BMC Med Genet       Date:  2006-03-29       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.